Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T2345 vs Active Comparator in Newly Diagnosed Glaucoma
NCT01494753Phase 2Completed
- Sponsor
- Laboratoires Théa
- Start
- Jun 2008
- Primary completion
- Dec 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial of latanoprost in primary open-angle glaucoma (POAG) and ocular hypertension (2 arms), sponsored by Laboratoires Théa. Primary endpoint: Mean Intra Ocular Pressure at Day 84. Started Jun 2008; status: completed.
02
Drugs
latanoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01494753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494753.